Related Experiment Video
Updated: Jul 18, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients
1Division of Clinical Microbiology, Department of Laboratory Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Insights
Hepatitis B and C virus infections are significantly prevalent in human immunodeficiency virus (HIV)-positive patients in New Delhi. Early detection of these hepatitis virus co-infections is crucial for managing HIV care.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Human immunodeficiency virus (HIV) infection is a global health concern.
- Coinfections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are common in HIV-positive individuals.
- These coinfections can accelerate liver disease progression and complicate treatment.
Purpose of the Study:
- To determine the prevalence of hepatitis B and C virus infections among HIV-positive patients.
- To compare infection rates with a control group of healthy donors.
- To inform clinical management strategies for HIV-infected patients.
Main Methods:
- Serum samples from 451 HIV-positive patients were tested for HBsAg and HCV antibodies.
- A control group of healthy bone-marrow and renal donors was included for comparison.
- Data were collected over a three-year period (January 2003 - December 2005).
Main Results:
- The prevalence of HBsAg was 5.3% in HIV-positive patients versus 1.4% in controls (P < 0.001).
- HCV co-infection prevalence was 2.43% in HIV patients, significantly higher than controls (0.7%, P < 0.05).
- No cases of triple infection (HIV, HBV, and HCV) were observed.
Conclusions:
- HIV-infected patients exhibit a significantly high prevalence of HBV and HCV infections.
- Hepatitis virus coinfections in HIV may lead to faster liver disease progression.
- Early screening for hepatitis virus coinfections in HIV patients is recommended to mitigate risks like hepatotoxicity from antiretroviral therapy.
Aim:
To determine the prevalence of hepatitis B and C virus infections in human immunodeficiency virus (HIV) -positive patients at a tertiary care hospital in New Delhi, India.
Methods:
Serum samples from 451 HIV positive patients were analyzed for HBsAg and HCV antibodies during three years (Jan 2003-Dec 2005). The control group comprised of apparently healthy bone-marrow and renal donors.
Results:
The study population comprised essentially of heterosexually transmitted HIV infection. The prevalence rate of HBsAg in this population was 5.3% as compared to 1.4% in apparently healthy donors (P < 0.001). Though prevalence of HCV co-infection (2.43%) was lower than HBV in this group of HIV positive patients, the prevalence was significantly higher (P < 0.05) than controls (0.7%). Triple infection of HIV, HBV and HCV was not detected in any patient.
Conclusion:
Our study shows a significantly high prevalence of hepatitis virus infections in HIV infected patients. Hepatitis viruses in HIV may lead to faster progression to liver cirrhosis and a higher risk of antiretroviral therapy induced hepatotoxicity. Therefore, it would be advisable to detect hepatitis virus co-infections in these patients at the earliest.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...